Search

Your search keyword '"Rouas, Ghizlane"' showing total 206 results

Search Constraints

Start Over You searched for: Author "Rouas, Ghizlane" Remove constraint Author: "Rouas, Ghizlane" Search Limiters Full Text Remove constraint Search Limiters: Full Text
206 results on '"Rouas, Ghizlane"'

Search Results

1. Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications.

3. The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer

4. The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab

7. ESR1 mutations in metastatic lobular breast cancer patients

8. Abstract PD4-01: PD4-01 Spatial transcriptomics reveals a substantial heterogeneity in TNBC tumor and stroma compartments with potential clinical implications

9. Abstract P2-21-01: Decoding Inter- and Intra-Tumor Heterogeneity in Lobular Breast Cancer Using Spatial Transcriptomics and Clustering Analysis

10. Timing evolution of lobular breast cancer through phylogenetic analysis

11. Timing evolution of lobular breast cancer through phylogenetic analysis.

12. Erratum: Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations

13. Abstract P4-02-02: The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer

14. Abstract PD14-02: Unravelling spatial tumor organization and heterogeneity in lobular breast cancer using spatial transcriptomics

15. Abstract P1-05-03: Integrating spatial transcriptomics and high-resolution morphological annotation to investigate tumor heterogeneity and PAM50 molecular subtyping in lobular breast cancer

16. Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients

17. Recapitulating spatial tumor morphology using automated classifier in triple negative breast cancer

18. Contribution of the tumor and stroma compartments for TNBC molecular classification using spatial transcriptomics analysis

19. Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients.

20. DNA methylation profiling reveals a predominant immune component in breast cancers

21. Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome.

22. Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome.

23. STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial.

24. Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome

25. ESR1 mutations in metastatic lobular breast cancer patients.

26. Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial.

28. Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial

29. Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues

30. Immune Infiltration in Invasive Lobular Breast Cancer.

31. p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.

32. Immune Infiltration in Invasive Lobular Breast Cancer.

33. Immune Infiltration in Invasive Lobular Breast Cancer

34. Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations.

35. Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations

36. Genomic Characterization of Primary Invasive Lobular Breast Cancer.

37. Detection of ESR1 mutations in matched primary and metastatic samples from endocrine-resistant lobular breast cancer patients

38. Exome sequencing of circulating tumor cells in metastatic breast cancer

39. Genomic Characterization of Primary Invasive Lobular Breast Cancer.

40. Lymphocytic infiltration in invasive lobular breast cancer.

41. Lymphocytic infiltration in invasive lobular breast cancer

42. Abstract P4-01-01: Circulating tumor cell (CTC) enumeration and HER2 assessment as predictors of breast cancer outcomes in the ALTTO (BIG 2-06, Alliance N063D) Trial

43. International study on inter-reader variability for circulating tumor cells in breast cancer.

44. Characterization and clinical relevance of the genomic alterations defining lobular breast cancer

45. Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment.

46. Characterization and clinical relevance of the genomic alterations defining lobular breast cancer.

47. Circulating tumor cell (CTC) enumeration and HER2 assessment as predictors of breast cancer outcomes in the ALTTO (BIG 2-06, Alliance N063D) Trial.

48. Evaluation of PI3K-pathway–activation status in matched primary (P) and metastatic (M) ER+/HER2- breast cancer (BC) lesions according to PIK3CA-mutation status.

49. International study on inter-reader variability for circulating tumor cells in breast cancer

50. Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients

Catalog

Books, media, physical & digital resources